Mohummad Minhaj Siddiqui

Mohummad Minhaj Siddiqui

Auto-generated profile, based on publicly available information

Mohummad Minhaj Siddiqui

Division of Urology, Department of Surgery, University of Maryland School of Medicine, Baltimore, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2015 in JAMA
Verified
Journal Article
Open access
PDF file
MSM. Minhaj Siddiqui
M. Minhaj Siddiqui
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami
BTBaris Turkbey
Baris Turkbey
AGArvin K. George
Arvin K. George
JRJason Rothwax
Jason Rothwax
PPPeter A. Pinto
Peter A. Pinto
The current diagnostic procedure for men suspected of prostate cancer is a standard extended-sextant biopsy (ie, standard biopsy). Unlike many other solid tumors for which image-guided biopsy is common, prostate cancer has traditionally been detected by randomly sampling the entire organ. However, the recent introduction of multiparametric magnetic resonance imaging (MP-MRI) now allows for imaging-based identification of prostate cancer, which may improve diagnostic accuracy for higher-risk tumors.1-5

12 November 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
PBPedro M. Baptista
Pedro M. Baptista
MSMohummad M. Siddiqui
Mohummad M. Siddiqui
GLGenevieve Lozier
Genevieve Lozier
SRSergio R. Rodriguez
Sergio R. Rodriguez
Anthony AtalaAnthony Atala
Anthony Atala
SSShay Soker
Shay Soker
A major roadblock to successful organ bioengineering is the need for a functional vascular network within the engineered tissue. Here, we describe the fabrication of three-dimensional, naturally derived scaffolds with an intact vascular tree. Livers from different species were perfused with detergent to selectively remove the cellular components of the tissue while preserving the extracellular matrix components and the intact vascular network. The decellularized vascular network was able to withstand fluid flow that entered through a central inlet vessel, branched into an extensive capillary bed, and coalesced into a single outlet vessel. The vascular network was used to reseed the scaffolds with human fetal liver and endothelial cells. These cells engrafted in their putative native locations within the decellularized organ and displayed typical endothelial, hepatic, and biliary epithelial markers, thus creating a liver-like tissue in vitro. Conclusion: These results represent a significant advancement in the bioengineering of whole organs. This technology may provide the necessary tools to produce the first fully functional bioengineered livers for organ transplantation and drug discovery. (HEPATOLOGY 2011;53:604-617)

1 November 2013 in European Urology
Verified
Journal Article
Closed access
MSM. Minhaj Siddiqui
M. Minhaj Siddiqui
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami
HTHong Truong
Hong Truong
LSLambros Stamatakis
Lambros Stamatakis
SVSrinivas Vourganti
Srinivas Vourganti
PPPeter A. Pinto
Peter A. Pinto

2 July 2013 in Cancer
Verified
Journal Article
Open access
PDF file
LSLambros Stamatakis
Lambros Stamatakis
MSM. Minhaj Siddiqui
M. Minhaj Siddiqui
JNJeffrey W. Nix
Jeffrey W. Nix
JLJennifer Logan
Jennifer Logan
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami
PPPeter A. Pinto
Peter A. Pinto
BACKGROUND: Active surveillance (AS) is an attempt to avoid overtreatment of clinically insignificant prostate cancer (PCa); however, patient selection remains controversial. Multiparametric prostate magnetic resonance imaging (MP‐MRI) may help better select AS candidates.METHODS: We reviewed a cohort of men who underwent MP‐MRI with MRI/Ultrasound fusion–guided prostate biopsy and selected potential AS patients at entry using Johns Hopkins criteria. MP‐MRI findings were assessed, including number of lesions, dominant lesion diameter, total lesion volume, prostate volume, and lesion density (calculated as total lesion volume/prostate volume). Lesions were assigned a suspicion score for cancer by MRI. AS criteria were reapplied based on the confirmatory biopsy, and accuracy of MP‐MRI in predicting AS candidacy was assessed. Logistic regression modeling and chi‐square statistics were used to assess associations between MP‐MRI interpretation and biopsy results.RESULTS: Eighty‐five patients qualified for AS with a mean age of 60.2 years and mean prostate‐specific antigen level of 4.8 ng/mL. Of these, 25 patients (29%) were reclassified as not meeting AS criteria based on confirmatory biopsy. Number of lesions, lesion density, and highest MRI lesion suspicion were significantly associated with confirmatory biopsy AS reclassification. These MRI‐based factors were combined to create a nomogram that generates a probability for confirmed AS candidacy.CONCLUSION: As clinicians counsel patients with PCa, MP‐MRI may contribute to the decision‐making process when considering AS. Three MRI‐based factors (number of lesions, lesion suspicion, and lesion density) were associated with confirmatory biopsy outcome and reclassification. A nomogram using these factors has promising predictive accuracy for which future validation is necessary. Cancer 2013;119:3359–66. Published 2013. This article is a U.S. Government work and is in the public domain in the USA

19 June 2017 in Frontiers in Oncology
Verified
Journal Article
Open access
EEEric Eidelman
Eric Eidelman
JTJeffrey Twum-Ampofo
Jeffrey Twum-Ampofo
JAJamal Ansari
Jamal Ansari
MSMohummad Minhaj Siddiqui
Mohummad Minhaj Siddiqui
Prostate cancer is the most common non-cutaneous cancer in men in the United States. Cancer metabolism has emerged as a contemporary topic of great interest for improved mechanistic understanding of tumorigenesis. Prostate cancer is a disease model of great interest from a metabolic perspective. Prostatic tissue exhibits unique metabolic activity under baseline conditions. Benign prostate cells accumulate zinc and this excess zinc inhibits citrate oxidation and metabolism within the citric acid cycle, effectively resulting in citrate production. Malignant cells, however, actively oxidize citrate and resume more typical citric acid cycle function. Of further interest, prostate cancer does not exhibit the Warburg effect, an increase in glucose uptake, seen in many other cancers. These cellular metabolic differences and others are of clinical interest as they present a variety of potential therapeutic targets. Furthermore, understanding of the metabolic profile differences between benign prostate versus low and high-grade prostate cancers also represents an avenue to better understand cancer progression and potentially develop new diagnostic testing. In this paper, we review the current state of knowledge on the metabolic phenotypes of prostate cancer.

1 November 2013 in Journal of Urology
Verified
Journal Article
Closed access
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami
MSM. Minhaj Siddiqui
M. Minhaj Siddiqui
BTBaris Turkbey
Baris Turkbey
LSLambros Stamatakis
Lambros Stamatakis
JLJennifer Logan
Jennifer Logan
PPPeter A. Pinto
Peter A. Pinto
We determine the usefulness of multiparametric magnetic resonance imaging in detecting prostate cancer, with a specific focus on detecting higher grade prostate cancer. Prospectively 583 patients who underwent multiparametric magnetic resonance imaging and subsequent prostate biopsy at a single institution were evaluated. On multiparametric magnetic resonance imaging, lesions were identified and scored as low, moderate or high suspicion for prostate cancer based on a validated scoring system. Magnetic resonance/ultrasound fusion guided biopsies of magnetic resonance imaging lesions in addition to systematic 12-core biopsies were performed. Correlations between the highest assigned multiparametric magnetic resonance imaging suspicion score and presence of cancer and biopsy Gleason score on the first fusion biopsy session were assessed using univariate and multivariate logistic regression models. Sensitivity, specificity, negative predictive value and positive predictive value were calculated and ROC curves were developed to assess the discriminative ability of multiparametric magnetic resonance imaging as a diagnostic tool for various biopsy Gleason score cohorts. Significant correlations were found between age, prostate specific antigen, prostate volume, and multiparametric magnetic resonance imaging suspicion score and the presence of prostate cancer (p<0.0001). On multivariate analyses controlling for age, prostate specific antigen and prostate volume, increasing multiparametric magnetic resonance imaging suspicion was an independent prognosticator of prostate cancer detection (OR 2.2, p<0.0001). Also, incremental increases in multiparametric magnetic resonance imaging suspicion score demonstrated stronger associations with cancer detection in patients with Gleason 7 or greater (OR 3.3, p<0.001) and Gleason 8 or greater (OR 4.2, p<0.0001) prostate cancer. Assessing multiparametric magnetic resonance imaging as a diagnostic tool for all prostate cancer, biopsy Gleason score 7 or greater, and biopsy Gleason score 8 or greater separately via ROC analyses demonstrated increasing accuracy of multiparametric magnetic resonance imaging for higher grade disease (AUC 0.64, 0.69, and 0.72, respectively). Multiparametric magnetic resonance imaging is a clinically useful modality to detect and characterize prostate cancer, particularly in men with higher grade disease.